Clinical Trials in Salt Lake City

Showing 4361-4380 of 16,694 trials

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

NCT06534424

This clinical trial evaluates the impact of enhanced risk assessments on knowledge, perceptions, and decisional conflict about cancer prevention in women with a BRCA1 or BRCA2 mutation. BRCA1/2 mutation carriers have a much higher risk of developing breast and ovarian cancer. Due to the high risk of cancer, mutation carriers are provided guidelines on more intensive screening and preventative surgeries such as bilateral mastectomy and bilateral salpingo-oophorectomy. Doctors want to learn if a more personalized risk assessment impacts the patients' risk perceptions and comfort with decision-making around cancer prevention behaviors.

BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome

Ohio State University Comprehensive Cancer Center152 participantsStarted Jan 2018

Columbus, Ohio, United States • Salt Lake City, Utah, United States

Active Not RecruitingPhase 1< 1 mile

FS120 Phase 1/1b Study in Patients With Advanced Malignancies

NCT04648202

This is a Phase 1/1b, multicenter, open label study to evaluate the Safety and Antitumor Activity of FS120, an OX40/CD137 Bispecific Antibody, Alone and in Combination with Pembrolizumab, in Subjects with Advanced Malignancies

Advanced CancerMetastatic Cancer

invoX Pharma Limited82 participantsStarted Nov 2020

New Haven, Connecticut, United States • Houston, Texas, United States • San Antonio, Texas, United States +6 more locations

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

FS120 Phase 1/1b Study in Patients With Advanced Malignancies

Find Trials by Condition in Salt Lake City

A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy

BIG Study (Brain, Immune, and Gut Health Evaluation of Infants/Young Children Fed Infant Formula, and Later Supplemental Toddler Nutrition, With 5 Specific HMOs)

DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors

Adolescent Master Protocol

Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD

Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast

LTFU for All Cell and Gene Therapy Studies

Registry of Arthrex Hand and Wrist Products

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Confirming the Effectiveness of Online Guided Self-Help Family-Based Treatment for Adolescent Anorexia Nervosa

A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients

The Biomarkers in the Hyperbaric Oxygen Brain Injury Treatment Trial (BioHOBIT)

Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics

Cough Reduction in IPF With Nalbuphine ER